Biogen operates several manufacturing facilities around the world. Together, they total 198,000 liters of bioreactor capacity, one of the largest among biotech companies worldwide.

Hillerød, Denmark

  • Large-scale manufacturing
  • Medical device assembly
  • Labeling and packing

Biogen’s Hillerød complex brings together all production-related facilities outside the U.S. and also plays a pivotal role in the company’s global supply network. The site includes a large-scale manufacturing facility; a facility for assembly, labeling and packing; quality-control laboratories and extensive quality-assurance and engineering organizations.

The Hillerød site is the single-largest foreign greenfield investment in Denmark. In 2013, Biogen earned AmCham’s Foreign Company Award in recognition for job creation and investment generated by the Hillerød complex.

Research Triangle Park (RTP), North Carolina

  • Large-scale manufacturing
  • Small-scale manufacturing
  • Flexible volume manufacturing

In 2013, RTP won the Facility of the Year award in the facility integration category from the International Society for Pharmaceutical Engineering, Pharmaceutical Processing magazine and INTERPHEX, one of the industry’s leading trade events. With this facility we introduced an innovative process for early-stage clinical products. Single-use technology in a closed system replaces the traditional stainless-steel systems. This increases flexibility and speed of supplying drugs for clinical studies, and reduces the environmental impacts of the manufacturing process.

Solothurn, Switzerland

Construction on this next-generation biologics manufacturing facility began in 2016 and is expected to be completed in 2019. The Solothurn facility will produce up to ten metric tons of antibody per year, helping us provide meaningful therapies to patients with serious medical conditions around the globe.

Learn more about Solothurn